Chairman of the Board of Directors of Holcim since 2003 and Chairman of the Board of the Holcim Foundation for Sustainable Construction. He is also Chairman of Avenir Suisse, Swiss liberal think tank and Chairman of Lonza a leading global contract manufacturer for the health care industry.. He began his professional career in Switzerland in 1970 with the Sandoz Group, where he held various positions, ultimately as CEO of Sandoz Pharma. In 2009, he was appointed to the Assembly of the International Committee of the Red Cross (ICRC). He studied history and art history at the University of Basel, Switzerland, where he obtained a PhD in philosophy. He also holds a post masters degree from the Harvard Business School.
For a reasonably open world
